PL1829545T3 - Produkty zawierające pochodną prostaglandyny F2 alfa - Google Patents

Produkty zawierające pochodną prostaglandyny F2 alfa

Info

Publication number
PL1829545T3
PL1829545T3 PL05819874T PL05819874T PL1829545T3 PL 1829545 T3 PL1829545 T3 PL 1829545T3 PL 05819874 T PL05819874 T PL 05819874T PL 05819874 T PL05819874 T PL 05819874T PL 1829545 T3 PL1829545 T3 PL 1829545T3
Authority
PL
Poland
Prior art keywords
prostaglandin
derivative
component
aqueous liquid
liquid preparation
Prior art date
Application number
PL05819874T
Other languages
English (en)
Inventor
Akio Kimura
Hiroshi Yamada
Takehiro Kado
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PL1829545T3 publication Critical patent/PL1829545T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10Homopolymers or copolymers of propene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10Homopolymers or copolymers of propene
    • C08L23/14Copolymers of propene
    • C08L23/142Copolymers of propene at least partially crystalline copolymers of propene with other olefins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PL05819874T 2004-12-24 2005-12-26 Produkty zawierające pochodną prostaglandyny F2 alfa PL1829545T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004374009 2004-12-24
EP05819874A EP1829545B1 (en) 2004-12-24 2005-12-26 Prostaglandin f2 alpha derivative containing products
PCT/JP2005/023704 WO2006068266A1 (ja) 2004-12-24 2005-12-26 プロスタグランジンF2a誘導体含有製品

Publications (1)

Publication Number Publication Date
PL1829545T3 true PL1829545T3 (pl) 2012-09-28

Family

ID=36601858

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05819874T PL1829545T3 (pl) 2004-12-24 2005-12-26 Produkty zawierające pochodną prostaglandyny F2 alfa

Country Status (14)

Country Link
US (1) US20070244196A1 (pl)
EP (1) EP1829545B1 (pl)
KR (1) KR101283874B1 (pl)
CN (1) CN101175496A (pl)
AT (1) ATE555792T1 (pl)
CA (1) CA2592474C (pl)
DK (1) DK1829545T3 (pl)
ES (1) ES2386148T3 (pl)
NO (1) NO338832B1 (pl)
PL (1) PL1829545T3 (pl)
PT (1) PT1829545E (pl)
RU (1) RU2391983C2 (pl)
SI (1) SI1829545T1 (pl)
WO (1) WO2006068266A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
CN106929477B (zh) * 2017-03-20 2020-01-10 江南大学 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2886035A (en) * 1955-07-29 1959-05-12 Cutter Lab Venoclysis apparatus
US2985920A (en) * 1958-03-26 1961-05-30 Seiberling Rubber Co Method of making a cored heel
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
JPH06285135A (ja) * 1993-03-31 1994-10-11 Kyoraku Co Ltd 薬液用プラスチック容器
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
JP2003138074A (ja) * 2001-10-30 2003-05-14 Japan Polychem Corp 医療用延伸ブロー容器
ATE450264T1 (de) * 2003-07-31 2009-12-15 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Also Published As

Publication number Publication date
WO2006068266A1 (ja) 2006-06-29
DK1829545T3 (da) 2012-07-23
NO20073767L (no) 2007-09-14
ES2386148T3 (es) 2012-08-10
CA2592474C (en) 2013-08-13
ATE555792T1 (de) 2012-05-15
EP1829545A4 (en) 2009-07-22
PT1829545E (pt) 2012-05-21
RU2007128318A (ru) 2009-01-27
SI1829545T1 (sl) 2012-08-31
RU2391983C2 (ru) 2010-06-20
KR101283874B1 (ko) 2013-07-08
NO338832B1 (no) 2016-10-24
EP1829545B1 (en) 2012-05-02
CN101175496A (zh) 2008-05-07
KR20070093997A (ko) 2007-09-19
US20070244196A1 (en) 2007-10-18
EP1829545A1 (en) 2007-09-05
CA2592474A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
NO20073353L (no) Produkt som har prostaglandin som har fluoratom i molekyl
PT1719438E (pt) Talheres descartáveis
WO2007130568A3 (en) Fabric treatment dispensing package
DE60217087D1 (en) Metallsalze von hexahydrophthalsäure als keimbildende additive für kristalline thermoplaste
WO2010014807A3 (en) Perfume compositions comprising functional perfume components
CA2596760A1 (en) Lens delivery system
WO2008090066A3 (en) Stabilization of uv-sensitive active ingredients
IN2014DN07569A (pl)
MXPA05009195A (es) Un kit de limpieza y/o un kit para lavado de vajilla que contienen un despachador generador de espuma y una composicion limpiadora y/o para el lavado de vajilla.
WO2008017676A3 (en) Method for densification of porous articles
TW200606230A (en) Adhesive for dermal patch and production process thereof
AR110068A2 (es) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas
EP1695630A4 (en) BOTTLE DRINK
BRPI0418474A (pt) solução aquosa parenteral estável
PL1829545T3 (pl) Produkty zawierające pochodną prostaglandyny F2 alfa
EP2289975A3 (en) Organopolysiloxane compound and amidoamine compound, and cosmetic preparation
PL1812542T3 (pl) Kompozycja środków zapachowych, zawierająca 3,7-dimetylookt-6-enonitryl (cytronelilonitryl) jako substytut
SG131915A1 (en) Granule mass
GB0410616D0 (en) Antiperspirant or deodorant compositions
WO2009011112A1 (ja) プロスタグランジンe1を含む安定な脂肪乳剤
WO2007107835A3 (en) Stable liquid formulations of antiepileptic agents
EP1666043A4 (en) PROSTAGLANDINENTHALTENDES PRODUCT
WO2009140104A3 (en) Stabilization of triphenylboron-pyridine
WO2007059896A3 (de) Agrochemische zusammensetzung
WO2010149514A3 (en) Antiperspirant compositions containing a fragrance oil